Related Experiment Videos

FGFR-TACC approaches the first turn in the race for targetable GBM mutations

Cameron Brennan1

  • 1Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, USA.

Neuro-Oncology
|April 8, 2017
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos